GB2211848B - Orthorhombic ciclosporin crystal form,process for its production and pharmaceutical compositions containing it. - Google Patents

Orthorhombic ciclosporin crystal form,process for its production and pharmaceutical compositions containing it.

Info

Publication number
GB2211848B
GB2211848B GB8829556A GB8829556A GB2211848B GB 2211848 B GB2211848 B GB 2211848B GB 8829556 A GB8829556 A GB 8829556A GB 8829556 A GB8829556 A GB 8829556A GB 2211848 B GB2211848 B GB 2211848B
Authority
GB
United Kingdom
Prior art keywords
ciclosporin
orthorhombic
production
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8829556A
Other versions
GB2211848A (en
GB8829556D0 (en
Inventor
Danielle Giron
Martin List
Friedrich Richter
Yasuyuki Uike
Hans Peter Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8829556D0 publication Critical patent/GB8829556D0/en
Publication of GB2211848A publication Critical patent/GB2211848A/en
Application granted granted Critical
Publication of GB2211848B publication Critical patent/GB2211848B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
GB8829556A 1987-12-21 1988-12-19 Orthorhombic ciclosporin crystal form,process for its production and pharmaceutical compositions containing it. Expired - Lifetime GB2211848B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28

Publications (3)

Publication Number Publication Date
GB8829556D0 GB8829556D0 (en) 1989-02-08
GB2211848A GB2211848A (en) 1989-07-12
GB2211848B true GB2211848B (en) 1991-11-06

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8829556A Expired - Lifetime GB2211848B (en) 1987-12-21 1988-12-19 Orthorhombic ciclosporin crystal form,process for its production and pharmaceutical compositions containing it.

Country Status (27)

Country Link
JP (1) JPH0791316B2 (en)
KR (1) KR100188305B1 (en)
AT (1) AT403163B (en)
AU (1) AU626274B2 (en)
BE (1) BE1002665A4 (en)
CA (1) CA1341396C (en)
CH (1) CH677926A5 (en)
CY (1) CY1799A (en)
DE (1) DE3843054C2 (en)
DK (1) DK175220B1 (en)
ES (1) ES2012580A6 (en)
FI (1) FI89065C (en)
FR (1) FR2624863B1 (en)
GB (1) GB2211848B (en)
GR (1) GR1002486B (en)
HK (1) HK102894A (en)
HU (1) HU203564B (en)
IE (1) IE62006B1 (en)
IL (1) IL88719A0 (en)
IT (1) IT1235356B (en)
LU (1) LU87409A1 (en)
MY (1) MY103943A (en)
NL (1) NL195096C (en)
NO (1) NO177228C (en)
NZ (1) NZ227384A (en)
SE (1) SE503174C2 (en)
SG (1) SG99494G (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
KR20140100966A (en) 2011-11-15 2014-08-18 알러간, 인코포레이티드 Sustained action formulation of cyclosporin form 2

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
JP3631490B2 (en) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 Cyclosporine-containing ophthalmic composition
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
RU2158601C2 (en) 1994-11-03 2000-11-10 Новартис Аг Novel medicinal forms of cyclosporine for oral administration having simple formulation and bioavailability, and method of preparation thereof
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19549852B4 (en) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin containing preparations
US6262054B1 (en) * 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
RU2211047C2 (en) 1997-01-30 2003-08-27 Новартис Аг Gelatin capsule with solid film including oil-free pharmaceutically compositions
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
AU2005209201B2 (en) 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
CN1763084B (en) * 2005-10-11 2010-04-21 山东新时代药业有限公司 High purity cyclosporin A preparation method
US8772245B2 (en) * 2011-05-27 2014-07-08 Allergan, Inc. Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof
BR112014011768A2 (en) * 2011-11-15 2017-05-09 Allergan Inc cyclosporine a form 2 and its production method
KR102015151B1 (en) 2011-11-15 2019-08-27 알러간, 인코포레이티드 Autoclavable suspensions of cyclosporin a form 2
WO2013074625A1 (en) * 2011-11-15 2013-05-23 Allergan, Inc. Suspensions of cyclosporin a form 2
WO2024085235A1 (en) * 2022-10-20 2024-04-25 中外製薬株式会社 Method for producing cyclic peptide crystals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (en) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (en) * 1977-05-10 1978-11-23 Sandoz Ag CYCLOSPORIN DERIVATIVES, THEIR USE AND MANUFACTURING
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Total synthesis-change in molecular structure-biological effect: Ciclosporin as example". cont. *
cont. "Sandorama" 1984/III, R.Wenger. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
KR20140100966A (en) 2011-11-15 2014-08-18 알러간, 인코포레이티드 Sustained action formulation of cyclosporin form 2

Also Published As

Publication number Publication date
SG99494G (en) 1994-10-28
NZ227384A (en) 1991-09-25
HK102894A (en) 1994-09-30
DK705488A (en) 1989-06-22
IE62006B1 (en) 1994-12-14
SE8804570L (en) 1989-06-22
FI89065C (en) 1993-09-30
FI885869A (en) 1989-06-22
IL88719A0 (en) 1989-07-31
KR100188305B1 (en) 1999-06-01
DK175220B1 (en) 2004-07-12
SE8804570D0 (en) 1988-12-19
JPH01211598A (en) 1989-08-24
GB2211848A (en) 1989-07-12
IE883779L (en) 1989-06-21
AT403163B (en) 1997-11-25
AU626274B2 (en) 1992-07-30
NL8803125A (en) 1989-07-17
AU2705588A (en) 1989-06-22
NO885625L (en) 1989-06-22
HU203564B (en) 1991-08-28
IT1235356B (en) 1992-06-30
FR2624863B1 (en) 1991-04-26
DK705488D0 (en) 1988-12-19
NL195096C (en) 2004-02-09
FI885869A0 (en) 1988-12-19
GR1002486B (en) 1996-12-09
CY1799A (en) 1995-02-17
CA1341396C (en) 2002-11-05
GR880100850A (en) 1994-03-31
IT8848690A0 (en) 1988-12-20
NO177228B (en) 1995-05-02
ATA309588A (en) 1997-04-15
HUT49893A (en) 1989-11-28
DE3843054A1 (en) 1989-07-27
NO177228C (en) 1995-08-09
LU87409A1 (en) 1989-07-07
ES2012580A6 (en) 1990-04-01
BE1002665A4 (en) 1991-04-30
GB8829556D0 (en) 1989-02-08
KR890009975A (en) 1989-08-05
FR2624863A1 (en) 1989-06-23
MY103943A (en) 1993-10-30
DE3843054C2 (en) 2003-08-21
SE503174C2 (en) 1996-04-15
NO885625D0 (en) 1988-12-19
JPH0791316B2 (en) 1995-10-04
FI89065B (en) 1993-04-30
CH677926A5 (en) 1991-07-15

Similar Documents

Publication Publication Date Title
GB2211848B (en) Orthorhombic ciclosporin crystal form,process for its production and pharmaceutical compositions containing it.
HUT45954A (en) Process for producing tetrahydronaphtalene- and indanederivatives and pharmaceutical compositions containing them
IL74681A0 (en) Cyclosporins,their production and pharmaceutical compositions containing them
HK188195A (en) Stabilized pharmaceutical composition and its production
SG4292G (en) Chocolate additive,chocolate containing the same and process for producing such chocolate
IL82231A (en) 1-hydroxy-2-pyridones,process for their preparation and pharmaceutical compositions which contain them
HUT48624A (en) Process for producing 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions comprising such compounds
HUT49481A (en) Improved process for producing pharmaceutical compositions containing calcium-salts
HUT47278A (en) Process for producing pyrrolo-benzimidazols and pharmaceutical compositions containing them
HUT50121A (en) Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them
IL86094A (en) Crystalline human proinsulin, process for its production and pharmaceutical compositions containing it
EP0251453A3 (en) Substituted amino-dihydrooxazoles, -thiazoles and -imidazoles, process for their preparation and pharmaceutical compositions containing them
HUT46303A (en) Process for producing 3-/omega-/3,5-di-/tetrabutil/-4-hydroxy-phenyl/-alkanoyl/-pyrroles andtheyr deoxy-analogues and pharmaceutical compositions containing them
IL88927A0 (en) Thienoazepines,their production and pharmaceutical compositions containing them
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
ZA87520B (en) 8alpha-acylaminoergolines,their production and pharmaceutical compositions containing them
IL84955A0 (en) Novel carbamoyloxylabdanes,process for the preparation thereof and pharmaceutical compositions containing them
JPS6468379A (en) Novel compound, its production and pharmaceutical composition containing the same
IL87912A0 (en) Renin-inhibiting dipeptides,a process for the preparation thereof and pharmaceutical compositions containing them
HUT49332A (en) Process for producing n-/substituted -alkylidene/-1,2,3,4-tetrahydro-9-acridin-amides and pharmaceutical compositions containing them
AU589933B2 (en) 8 alpha-acylaminoergoline, its production and pharmaceutical compositions containing it
HUT44942A (en) Process for producing pharmaceutical compositions for inhibiting thromogenesis
IL72917A (en) Antibiotic albicidin,process for its production and pharmaceutical compositions containing it
HUT45261A (en) Process for producing 7-oxo-4-thia-1-aza-bicyclo/3.2.0/-hept-2-ene derivatives and pharmaceutical compositions containing them
HUT49127A (en) Process for producing new 2,3-thiomorpholindion-2-oxim derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20081218